Press Release: Nano Dimension Reports First Quarter 2025 Financial Results

Dow Jones
06/13

Core Business Revenue of $14.4 Million, 8% Higher Year-Over-Year

Conference Call Today at 4:30 PM EDT

WALTHAM, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, today announced its financial results for the first quarter ended March 31, 2025.

The following information does not reflect the results or impact of Desktop Metal, Inc. ("Desktop Metal") or Markforged Holding Corporation ("Markforged") unless stated otherwise, as transactions concerning these companies were completed after the conclusion of the first quarter.

First Quarter 2025 Highlights

   -- Revenue: $14.4 million, an 8% increase from $13.4 million year-over-year 
 
   -- Gross Margin ("GM"): 41%, down from 46% year-over-year 
 
   -- Adjusted Gross Margin ("Adjusted GM"): 44%, down from 50% year-over-year 
 
   -- Adjusted EBITDA loss: $9.0 million, down from a loss of $13.6 million or 
      33% improved year-over-year 
 
   -- Net Loss: $24.0 million, down from a loss of $35.0 million or 31% 
      improved year-over-year 
 
   -- Total Cash, cash equivalents, deposits and investable securities: $840 
      million as of March 31, 2025, down from $907 million year-over-year 

Details regarding Adjusted EBITDA and Adjusted Gross Margin can be found below in this press release under "Non-IFRS Measures."

Ofir Baharav, Chief Executive Officer, commented, "In spite of the challenging economic environment, we were able to grow revenue while meeting our cost cutting commitments. Our transformation is well underway as we focused the Core business on the most impactful, high-performance customer solutions, and applied a disciplined operating model to drive efficiency and long-term value creation. We took action designed to realize more than $20 million in annualized operating costs savings from Q4 2025 onwards, targeting an improvement of revenue per employee of approximately 50% over historical levels.

"Since our Markforged acquisition in April 2025, we've been applying the same rigorous approach to ensure their alignment with our financial and operational standards and we are well on our way to realize operational synergies, along with product and customer focus.

"This is a pivotal time for Nano Dimension. We remain focused on building a scalable, profitable platform, and will continue updating shareholders, including in regard to Desktop Metal's ongoing strategic assessment."

Business Transformation & Recent Developments

   -- Core Business Strategic Review: Delivered $20 million in annualized cost 
      savings from Q4 2025 onwards through: 
 
          -- Discontinuation of underperforming product lines including Admatec, 
             DeepCube, Fabrica, and Formatec. 
 
          -- Targeted headcount reductions and process optimization while 
             preserving investment in high-growth areas. 
 
   -- Desktop Metal Acquisition (Closed April 2, 2025): 
 
          -- Desktop Metal has initiated an independent strategic assessment to 
             address liabilities and liquidity issues. 
 
   -- Markforged Acquisition (Closed April 25, 2025): 
 
          -- Post-merger integration underway, following the same playbook 
             applied to Core business. 
 
   -- Operational Leveraging: 
 
          -- Reviewing manufacturing footprint for optimization opportunities. 
 
          -- Unifying software division to build a scalable platform and reduce 
             backend costs. 
 
   -- Product Innovation: 
 
          -- Launched FOX Ultra and PUMA Ultra, next-gen SMT solutions from 
             Essemtec. 
 
   -- Corporate governance: 
 
          -- Strengthening of board of directors with the addition of 
             technology and growth experts Andy Sriubas and Eileen Tanghal 
             (June 11, 2025) 

Financial results in detail

First Quarter 2025 Financial Results

   -- Total revenues for the first quarter of 2025 were $14.4 million, compared 
      to $13.4 million in the first quarter of 2024. The increase is attributed 
      mostly to increased sales efforts for Nano Dimension's diversified 
      product portfolio. 
 
   -- Total cost of revenues for the first quarter of 2025 was $8.5 million, 
      compared to $7.2 million in the first quarter of 2024. The increase is 
      mainly attributed to the above-mentioned increase in revenues. 
 
   -- Research and development ("R&D") expenses for the first quarter of 2025 
      were $5.0 million, compared to $9.1 million in the first quarter of 2024. 
      The decrease is mainly attributed to a decrease in payroll and related 
      expenses, share-based payments, subcontractor and professional fees and 
      other R&D expenses. 
 
   -- Sales and marketing ("S&M") expenses for the first quarter of 2025 were 
      $5.5 million, compared to $6.5 million in the first quarter of 2024. The 
      decrease is mainly attributed to payroll and related expenses, as well as 
      share-based payments and other S&M expenses. 
 
   -- General and administrative ("G&A") expenses for the first quarter of 2025 
      were $3.5 million, compared to $9.6 million in the first quarter of 2024. 
      The decrease is mainly attributed to a decrease in share-based payments, 
      professional services and payroll and related expenses. 
 
   -- Other expenses for the first quarter of 2025 were $30.8 million, compared 
      to other income, net of $109 thousand for the first quarter of 2024. In 
      the first quarter of 2025 the amount is mainly attributed to Desktop 
      Metal litigation related expenses. 
 
   -- Net loss attributable to owners for the first quarter of 2025 was $23.8 
      million or $0.11 loss per share, compared to net loss of $34.8 million, 
      or $0.15 loss per share, in the first quarter of 2024. 

Conference Call Today

Nano Dimension will host a conference call to discuss its financial results and strategic outlook today, June 12, 2025, at 4:30 p.m. EDT.

Participants can also dial-in/connect by following the below:

   -- Listen in via US dial-in: 1-844-695-5517 
 
   -- Listen via international dial-in: 1-412-902-6751 
 
   -- Listen and view presentation via webcast: 
      https://event.choruscall.com/mediaframe/webcast.html?webcastid=uKTBW5Ak 
 

For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension's website at http://investors.nano-di.com/events-and-presentations.

About Nano Dimension

Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices.

For more information, please visit https://www.nano-di.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding Nano's future growth, strategic plan and value to shareholders, and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Such statements are based on management's beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Nano's annual report on Form 20-F filed with the Securities and Exchange Commission (the "SEC") on May 12, 2025, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

Contacts:

Investors: nano-di@icrinc.com

Media: NanoDimension@feintuchpr.com

 
 
      Unaudited Consolidated Statements of Financial Position 
                                as at 
                        (In thousands of USD) 
 
                                   March 31,           December 31, 
                            ------------------------  -------------- 
                               2024         2025         2024(1) 
                            -----------  -----------  -------------- 
                            (Unaudited)  (Unaudited) 
Assets 
   Cash and cash 
    equivalents                251,858      487,438       317,169 
   Bank deposits               541,164      257,227       440,790 
   Restricted deposits              60           60           537 
   Trade receivables            11,840       12,300         9,141 
   Other receivables             6,419        5,076         4,790 
   Inventory                    19,698       16,832        16,899 
                            ----------   ----------   ----------- 
Total current assets           831,039      778,933       789,326 
 
   Restricted deposits             879          766           768 
   Investment in 
    securities                 112,657       94,915        86,190 
   Property plant and 
    equipment, net              16,078       13,057        14,143 
   Right-of-use assets          11,084        8,484         9,307 
   Intangible assets             2,235        2,076         2,155 
                            ----------   ----------   ----------- 
Total non-current assets       142,933      119,298       112,563 
                            ----------   ----------   ----------- 
Total assets                   973,972      898,231       901,889 
                            ----------   ----------   ----------- 
 
Liabilities 
   Trade payables                4,123       30,685         4,249 
   Other payables               21,837       18,798        22,461 
   Current portion of 
    lease liability              4,317        3,921         3,968 
   Current portion of bank 
    loan                           138          142           138 
                            ----------   ----------   ----------- 
Total current liabilities       30,415       53,546        30,816 
                            ----------   ----------   ----------- 
 
   Liability in respect of 
    government grants            1,989          873           843 
   Employee benefits             4,009        4,827         4,700 
   Long term lease 
    liability                    7,900        5,855         6,547 
   Bank loan                       380          248           276 
Total non-current 
 liabilities                    14,278       11,803        12,366 
                            ----------   ----------   ----------- 
Total liabilities               44,693       65,349        43,182 
                            ----------   ----------   ----------- 
 
Equity 
   Non-controlling 
    interests                      857          491           715 
   Share capital               404,366      410,973       409,145 
   Share premium and 
    capital reserves         1,298,973    1,300,382     1,304,617 
   Treasury shares            (149,461)    (167,651)     (167,651) 
   Foreign currency 
    translation reserve          1,249        1,625         1,044 
   Remeasurement of net 
    defined benefit 
    liability (IAS 19)            (726)      (2,062)       (2,062) 
   Accumulated loss           (625,979)    (710,876)     (687,101) 
                            ----------   ----------   ----------- 
Equity attributable to 
 owners of the Company         928,422      832,391       857,992 
                            ----------   ----------   ----------- 
Total equity                   929,279      832,882       858,707 
                            ----------   ----------   ----------- 
Total liabilities and 
 equity                        973,972      898,231       901,889 
                            ----------   ----------   ----------- 
 

___________________

(1) The December 31, 2024, balances were derived from the Company's audited annual financial statements

 
 
         Unaudited Consolidated Statements of Profit or Loss 
                    and Other Comprehensive Income 
            (In thousands of USD, except per share amounts) 
 
                                 Three Months Ended      Year ended 
                                      March 31,          December 31, 
                               ----------------------  --------------- 
                                   2024        2025         2024 
                               ------------  --------  --------------- 
Revenues                         13,364       14,401         57,775 
Cost of revenues                  7,142        8,392         31,125 
Cost of revenues - write-down 
 of inventories and 
 amortization of technology          44          103          1,655 
                               --------      -------   ------------ 
Total cost of revenues            7,186        8,495         32,780 
                               --------      -------   ------------ 
Gross profit                      6,178        5,906         24,995 
Research and development 
 expenses                         9,133        4,977         37,157 
Sales and marketing expenses      6,517        5,506         26,951 
General and administrative 
 expenses                         9,602        3,472         40,059 
Other expenses (income), net       (109)      30,810          5,966 
Impairment losses                    --        1,229          1,283 
                               --------      -------   ------------ 
Operating loss                  (18,965)     (40,088)       (86,421) 
Finance income                   11,311       18,035         43,540 
Finance expenses                 27,324        1,935         53,645 
                               --------      -------   ------------ 
Loss before taxes on income     (34,978)     (23,988)       (96,526) 
Taxes (expenses) benefit             16          (23)          (397) 
                               --------      -------   ------------ 
Loss for the period             (34,962)     (24,011)       (96,923) 
                               ========      =======   ============ 
Loss attributable to 
 non-controlling interests         (190)        (236)        (1,029) 
Loss attributable to owners     (34,772)     (23,775)       (95,894) 
 
Loss per share 
Basic loss per share              (0.15)       (0.11)         (0.44) 
 
Other comprehensive income 
items that after initial 
recognition in comprehensive 
income were or will be 
transferred to profit or 
loss 
Foreign currency translation 
 differences for foreign 
 operations                      (1,704)         593         (1,944) 
Other comprehensive income 
items that will not be 
transferred to profit or 
loss 
Remeasurement of net defined 
 benefit liability (IAS 19), 
 net of tax                      (1,433)          --         (2,769) 
Total other comprehensive 
 income (loss) for the 
 period                          (3,137)         593         (4,713) 
Total comprehensive loss for 
 the period                     (38,099)     (23,418)      (101,636) 
Comprehensive loss 
 attributable to 
 non-controlling interests         (214)        (224)        (1,088) 
Comprehensive loss 
 attributable to owners of 
 the Company                    (37,885)     (23,194)      (100,548) 
                               --------      -------   ------------ 
 
 
 
                                  Consolidated Statements of Changes in Equity (Unaudited) 
                                                    (In thousands of USD) 
 
                            Share 
                            premium 
                              and      Remeasurement              Foreign                              Non- 
                  Share     capital          of        Treasury   currency  Accumulated             controlling     Total 
                 capital   reserves        IAS 19        shares   reserve       loss      Total      interests      equity 
                 -------  ----------  ---------------  ---------  --------  -----------  --------  -------------  ---------- 
Balance as of 
 December 31, 
 2024            409,145  1,304,617       (2,062)      (167,651)     1,044    (687,101)  857,992        715       858,707 
Loss for the 
 period               --         --           --             --         --     (23,775)  (23,775)      (236)      (24,011) 
Other 
 comprehensive 
 income for the 
 period               --         --           --             --        581          --       581         12           593 
Exercise of 
 warrants, 
 options and 
 vesting of 
 RSUs              1,828     (1,828)          --             --         --          --        --         --            -- 
Share-based 
 payments             --     (2,407)          --             --         --          --    (2,407)        --        (2,407) 
                 -------  ---------   ----------  ---  --------   --------  ----------   -------   --------  ---  ------- 
Balance as of 
 March 31, 
 2025            410,973  1,300,382       (2,062)      (167,651)     1,625    (710,876)  832,391        491       832,882 
                 -------  ---------   ----------       --------   --------  ----------   -------   --------  ---  ------- 
 
 
 
          Consolidated Statements of Cash Flows (Unaudited) 
                         (In thousands of USD) 
 
                                  Three Months Ended      Year ended 
                                       March 31,          December 31 
                                ----------------------  -------------- 
                                    2024        2025         2024 
                                ------------  --------  -------------- 
Cash flow from operating 
activities: 
Net loss                         (34,962)     (24,011)      (96,923) 
Adjustments: 
Depreciation and amortization      2,066        1,500         6,675 
Impairment losses                     --        1,229         1,283 
Financing income, net             (9,798)      (7,383)      (42,183) 
Loss (gain) from revaluation 
 of financial assets and 
 liabilities accounted at fair 
 value                            25,811       (8,717)       52,288 
Share-based payments               3,460       (2,407)       13,883 
Other                                 43          (32)          217 
                                --------      -------   ----------- 
                                  21,582      (15,810)       32,163 
Changes in assets and 
liabilities: 
Decrease (increase) in 
 inventory                        (2,287)         340           387 
Decrease (increase) in other 
 receivables                       4,589         (371)        6,078 
Decrease (increase) in trade 
 receivables                         313       (2,881)        2,950 
Decrease in other payables        (1,917)      (4,026)       (1,150) 
Increase (decrease) in 
 employee benefits                    51           38          (562) 
Increase (decrease) in trade 
 payables                           (345)      26,362            47 
                                     404       19,462         7,750 
                                --------      -------   ----------- 
Net cash used in operating 
 activities                      (12,976)     (20,359)      (57,010) 
                                --------      -------   ----------- 
 
Cash flow from investing 
activities: 
Change in bank deposits           (6,594)     177,395       100,530 
Interest received                 17,154       14,010        42,806 
Change in restricted bank 
 deposits                            (11)         474          (377) 
Acquisition of property plant 
 and equipment                      (776)        (295)       (2,196) 
Acquisition of intangible 
 asset                              (711)          --          (711) 
                                --------      -------   ----------- 
Net cash from investing 
 activities                        9,062      191,584       140,052 
                                --------      -------   ----------- 
 
Cash flow from financing 
activities: 
Lease payments                    (1,140)      (1,082)       (4,524) 
Repayment long-term bank debt        (73)         (35)         (180) 
Proceeds from non-controlling 
 interests                            --           --           555 
Amounts recognized in respect 
 of government grants 
 liability                           (36)         (43)         (180) 
Payments of share price 
 protection recognized in 
 business combination               (363)          --          (363) 
Repurchase of treasury shares    (51,565)          --       (69,755) 
                                --------      -------   ----------- 
Net cash used in financing 
 activities                      (53,177)      (1,160)      (74,447) 
                                --------      -------   ----------- 
Increase (decrease) in cash 
 and cash equivalents            (57,091)     170,065         8,595 
                                ========      =======   =========== 
Cash and cash equivalents at 
 beginning of the period         309,571      317,169       309,571 
Effect of exchange rate 
 fluctuations on cash               (622)         204          (997) 
Cash and cash equivalents at 
 end of the period               251,858      487,438       317,169 
                                --------      -------   ----------- 
 
Non-cash transactions: 
Property plant and equipment 
 acquired on credit                  286           54            69 
Recognition of a right-of-use 
 asset                               158           55         1,275 
 
 

Non-IFRS Measures

The following are reconciliations of income before taxes, as calculated in accordance with International Financial Reporting Standards ("IFRS"), to EBITDA and Adjusted EBITDA, as well as of gross profit, as calculated in accordance with IFRS, to Adjusted Gross Profit:

 
                                                 For the Three-Month Period 
                                                    Ended March 31, 2025 
                                                ---------------------------- 
                                                    In thousands of USD 
                                                ---------------------------- 
Net loss                                                        (24,011) 
Tax expenses                                                         23 
Depreciation and amortization                                     1,500 
Interest income                                                  (9,309) 
                                                ----------------------- 
EBITDA (loss)                                                   (31,797) 
Finance income from revaluation of assets and 
 liabilities                                                     (8,396) 
Exchange rate differences                                         1,573 
Share-based payments                                             (2,407) 
Desktop Metal litigation related expenses                        28,069 
Desktop Metal and Markforged transaction 
 related expenses                                                 1,515 
Restructuring costs                                               1,180 
Impairment losses                                                 1,229 
                                                -----------------------  --- 
Adjusted EBITDA (loss)                                           (9,034) 
 
Gross profit                                                      5,906 
Depreciation and amortization                                       209 
Share-based payments                                                190 
Adjusted gross profit                                             6,305 
                                                -----------------------  --- 
 
 

EBITDA is a non-IFRS measure and is defined as earnings before interest income, income tax, depreciation and amortization. We believe that EBITDA, as described above, should be useful in evaluating the performance of our business. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to the items mentioned above.

Adjusted EBITDA is a non-IFRS measure and is defined as earnings before interest income, income tax, depreciation and amortization, share-based payments, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs and impairment losses. We believe that Adjusted EBITDA, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payment payments, restructuring costs and impairment losses, and Adjusted EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to non-cash items, such as expenses related to share-based payments.

Adjusted gross profit, excluding depreciation and amortization and share-based compensation expenses, is a non-IFRS measure and is defined as gross profit excluding amortization expenses. We believe that adjusted gross profit, as described above, should also be useful in evaluating the performance of our business. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company's performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.

EBITDA and Adjusted EBITDA, and Adjusted gross profit can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison

(END) Dow Jones Newswires

June 12, 2025 16:05 ET (20:05 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10